ID   DFT2.JV
AC   CVCL_A1TN
SY   JV
DR   Wikidata; Q105506748
RX   PubMed=26711993;
RX   PubMed=32937435;
CC   Group: Marsupial cell line.
DI   NCIt; C176224; Devil facial tumor disease 2
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB80 ! DFT2.RV
OI   CVCL_A1YH ! DFT2.SN
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
RX   PubMed=26711993; DOI=10.1073/pnas.1519691113; PMCID=PMC4720317;
RA   Pye R.J., Pemberton D., Tovar Lopez C.D., Tubio J.M.C., Dun K.A.,
RA   Fox S., Darby J.M., Hayes D., Knowles G.W., Kreiss A., Siddle H.V.T.,
RA   Swift K., Lyons A.B., Murchison E.P., Woods G.M.;
RT   "A second transmissible cancer in Tasmanian devils.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:374-379(2016).
//
RX   PubMed=32937435; DOI=10.1126/sciadv.aba5031; PMCID=PMC7458443;
RA   Flies A.S., Darby J.M., Lennard P.R., Murphy P.R., Ong C.E.B.,
RA   Pinfold T.L., De Luca A., Lyons A.B., Woods G.M., Patchett A.L.;
RT   "A novel system to map protein interactions reveals evolutionarily
RT   conserved immune evasion pathways on transmissible cancers.";
RL   Sci. Adv. 6:eaba5031.1-eaba5031.13(2020).
//